{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:05:03Z","timestamp":1773284703540,"version":"3.50.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"vor","delay-in-days":302,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Zhongshan Funds for the Institute of Vascular Surgery, Fudan University"},{"name":"Fudan University \u201cStar of Tomorrow\u201d Famous Doctor Training Project"},{"DOI":"10.13039\/501100012247","name":"Shanghai Excellent Academic Leader","doi-asserted-by":"publisher","award":["19XD1401200"],"award-info":[{"award-number":["19XD1401200"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Excellent Core Member Training Program at Zhongshan Hospital, Fudan University, China","award":["2015ZSYXGG02"],"award-info":[{"award-number":["2015ZSYXGG02"]}]},{"DOI":"10.13039\/501100001809","name":"China National Natural Science","doi-asserted-by":"crossref","award":["81900426"],"award-info":[{"award-number":["81900426"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"China National Natural Science","doi-asserted-by":"crossref","award":["81970407"],"award-info":[{"award-number":["81970407"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"China National Natural Science","doi-asserted-by":"crossref","award":["30801122"],"award-info":[{"award-number":["30801122"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Training Program for Outstanding Academic Leaders of the Shanghai Health and Family Planning System","award":["2018BR40"],"award-info":[{"award-number":["2018BR40"]}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["19XD1401200"],"award-info":[{"award-number":["19XD1401200"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>For patients with angiitis-induced critical limb ischemia (AICLI), cell transplantation, such as purified CD34+ cells (PCCs) and peripheral blood mononuclear cells (PBMNCs), is gradually being used as a promising treatment. This was the first randomized single-blinded noninferiority trial (number: NCT 02089828) specifically designed to evaluate the therapeutic efficacies of the transplantation of PCCs vs those of PBMNCs for the treatment of AICLI. We aimed to compare the mid-term safety and efficacy between the two groups and determine their respective advantages. From April 2014 to September 2019, 50 patients with AICLI were equally allocated to the two groups, except for 1 lost patient, 1 amputee, and 1 patient who died of heart disease. The other 47 patients completed the 36-month follow-up. The endpoints were as follows: major amputation-free survival and total amputation-free survival at 6 months, which were 96.0% and 84.0% in the PBMNCs group and 96.0% and 72.0% in the PCCs group, respectively. These rates remained stable at 12, 24, and 36\u2009months. The PCCs group had a significant higher probability of rest pain relief than the PBMNCs group, whereas earlier significant improvements in the Rutherford classification were observed in the PBMNCs group. Accordingly, PCCs would be preferred for patients with significant pain, whereas PBMNCs may be a good option for patients with two or more critically ischemic limbs. Concerning cost-effectiveness, PCCs are not more cost-effective than PBMNCs. These outcomes require verification from long-term trials involving larger numbers of patients.<\/jats:p>","DOI":"10.1002\/sctm.20-0033","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T04:47:38Z","timestamp":1609908458000},"page":"647-659","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Three-year outcomes of peripheral blood mononuclear cells vs purified CD34+ cells in the treatment of angiitis-induced no-option critical limb ischemia and a cost-effectiveness assessment: A randomized single-blinded noninferiority trial"],"prefix":"10.1093","volume":"10","author":[{"given":"Hao","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Vascular Surgery of Zhongshan Hospital Fudan University, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyue","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery of Zhongshan Hospital Fudan University, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery of Zhongshan Hospital Fudan University, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery of Zhongshan Hospital Fudan University, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery of Zhongshan Hospital Fudan University, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolang","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery of Zhongshan Hospital Fudan University, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery of Zhongshan Hospital Fudan University, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Hematology of Zhongshan Hospital Fudan University, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyang","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Hematology of Zhongshan Hospital Fudan University, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology of Zhongshan Hospital Fudan University, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguo","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery of Zhongshan Hospital Fudan University, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihui","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery of Zhongshan Hospital Fudan University, Shanghai, People's Republic of China"},{"name":"Department of Project Management, Fudan Zhangjiang Institute, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"2022022810524117600_sct312877-bib-0001","first-page":"10","article-title":"Lower extremity critical limb ischemia: a review of clinical features and management","volume":"17","author":"Levin","year":"2019","journal-title":"Trends Cardiovasc Med"},{"key":"2022022810524117600_sct312877-bib-0002","doi-asserted-by":"crossref","first-page":"14445","DOI":"10.1002\/jcp.28141","article-title":"Critical limb ischemia: current and novel therapeutic strategies","volume":"234","author":"Hassanshahi","year":"2019","journal-title":"J Cell Physiol"},{"key":"2022022810524117600_sct312877-bib-0003","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/1526602817719283","article-title":"Midterm outcomes from a pilot study of percutaneous deep vein arterialization for the treatment of no-option critical limb ischemia","volume":"24","author":"Kum","year":"2017","journal-title":"J Endovasc Ther"},{"issue":"suppl S","key":"2022022810524117600_sct312877-bib-0004","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"2022022810524117600_sct312877-bib-0005","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jvs.2015.07.069","article-title":"Nonrevascularization-based treatments in patients with severe or critical limb ischemia","volume":"62","author":"Abu","year":"2015","journal-title":"J Vasc Surg"},{"key":"2022022810524117600_sct312877-bib-0006","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/dmrr.2399","article-title":"Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment","volume":"29","author":"Dubsky","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"2022022810524117600_sct312877-bib-0007","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCRESAHA.111.253286","article-title":"Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity","volume":"109","author":"Sahoo","year":"2011","journal-title":"Circ Res"},{"key":"2022022810524117600_sct312877-bib-0008","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/CIRCULATIONAHA.106.644518","article-title":"CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells","volume":"114","author":"Kawamoto","year":"2006","journal-title":"Circulation"},{"key":"2022022810524117600_sct312877-bib-0009","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ebiom.2018.08.038","article-title":"Purified CD34 cells versus peripheral blood mononuclear cells in the treatment of angiitis-induced no-option critical limb ischaemia: 12-month results of a prospective randomised single-blinded non-inferiority trial","volume":"35","author":"Dong","year":"2018","journal-title":"EBioMedicine"},{"key":"2022022810524117600_sct312877-bib-0010","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jvs.2013.01.037","article-title":"Transplantation of purified CD34+ cells in the treatment of critical limb ischemia","volume":"58","author":"Dong","year":"2013","journal-title":"J Vasc Surg"},{"key":"2022022810524117600_sct312877-bib-0011","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0895-4356(98)00095-X","article-title":"Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan","volume":"51","author":"Fukuhara","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2022022810524117600_sct312877-bib-0012","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0895-4356(98)00096-1","article-title":"Psychometric and clinical tests of validity of the Japanese SF-36 health survey","volume":"51","author":"Fukuhara","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"suppl 6","key":"2022022810524117600_sct312877-bib-0013","first-page":"17","article-title":"Quality-adjusted life years: population-specific measurement of the quality component","volume":"17","author":"McGhee","year":"2011","journal-title":"Hong Kong Med J"},{"key":"2022022810524117600_sct312877-bib-0014","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0895-4356(98)00103-6","article-title":"Deriving a preference-based single index from the UK SF-36 Health Survey","volume":"51","author":"Brazier","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2022022810524117600_sct312877-bib-0015","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/MAO.0000000000001389","article-title":"Cost-effectiveness of pediatric cochlear implantation in rural China","volume":"38","author":"Qiu","year":"2017","journal-title":"Otol Neurotol"},{"key":"2022022810524117600_sct312877-bib-0016","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1161\/01.CIR.0000134696.08436.65","article-title":"Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction","volume":"109","author":"Yoon","year":"2004","journal-title":"Circulation"},{"key":"2022022810524117600_sct312877-bib-0017","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCULATIONAHA.105.589937","article-title":"Increase in vascular permeability and vasodilation are critical for proangiogenic effects of stem cell therapy","volume":"114","author":"You","year":"2006","journal-title":"Circulation"},{"issue":"suppl 1","key":"2022022810524117600_sct312877-bib-0018","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1038\/ncpcardio0430","article-title":"Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI","volume":"3","author":"Shintani","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2022022810524117600_sct312877-bib-0019","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1161\/CIRCRESAHA.116.310557","article-title":"Angiogenic mechanisms of human CD34 stem cell exosomes in the repair of ischemic hindlimb","volume":"120","author":"Mathiyalagan","year":"2017","journal-title":"Circ Res"},{"key":"2022022810524117600_sct312877-bib-0020","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1161\/01.CIR.0000031332.45480.79","article-title":"Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs","volume":"106","author":"Iba","year":"2002","journal-title":"Circulation"},{"key":"2022022810524117600_sct312877-bib-0021","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/sctm.17-0252","article-title":"A five-year study of the efficacy of purified CD34+ cell therapy for angiitis-induced no-option critical limb ischemia","volume":"7","author":"Fang","year":"2018","journal-title":"stem cells translational med"},{"key":"2022022810524117600_sct312877-bib-0022","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1161\/01.CIR.0000099501.52718.70","article-title":"Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo","volume":"108","author":"Yeh","year":"2003","journal-title":"Circulation"},{"key":"2022022810524117600_sct312877-bib-0023","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jvs.2003.08.006","article-title":"Clinical and social consequences of Buerger disease","volume":"39","author":"Ohta","year":"2004","journal-title":"J Vasc Surg"},{"key":"2022022810524117600_sct312877-bib-0024","first-page":"80","article-title":"Long-term follow-up of thromboangiitis obliterans","volume":"27","author":"Borner","year":"1998","journal-title":"Vasa"},{"key":"2022022810524117600_sct312877-bib-0025","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.110.942383","article-title":"Thromboangiitis obliterans","volume":"121","author":"Piazza","year":"2010","journal-title":"Circulation"},{"key":"2022022810524117600_sct312877-bib-0026","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1253\/circj.CJ-14-0656","article-title":"Endarteritis obliterans in the pathogenesis of Buerger's disease from the pathological and immunohistochemical points of view","volume":"78","author":"Kobayashi","year":"2014","journal-title":"Circ J"},{"key":"2022022810524117600_sct312877-bib-0027","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/rheumatology\/ken210","article-title":"Prevalence, serological features, response to treatment and outcome of critical peripheral ischaemia in a cohort of lupus patients","volume":"47","author":"Jeffery","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"2022022810524117600_sct312877-bib-0028","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0049-0172(95)80010-7","article-title":"Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation","volume":"24","author":"Lie","year":"1995","journal-title":"Semin Arthritis Rheum"},{"key":"2022022810524117600_sct312877-bib-0029","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/CIRCRESAHA.116.309045","article-title":"Autologous cell therapy for peripheral arterial disease: systematic review and meta-analysis of randomized, nonrandomized, and noncontrolled studies","volume":"120","author":"Rigato","year":"2017","journal-title":"Circ Res"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/sctm.20-0033","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/sctm.20-0033","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/10\/5\/647\/42626959\/stcltm_10_5_647.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/10\/5\/647\/42626959\/stcltm_10_5_647.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T11:12:18Z","timestamp":1646046738000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/10\/5\/647\/6404149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,1,5]]},"published-print":{"date-parts":[[2021,5,1]]}},"URL":"https:\/\/doi.org\/10.1002\/sctm.20-0033","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,1]]},"published":{"date-parts":[[2021,1,5]]},"assertion":[{"value":"2020-01-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}